Storia in 5 fonti

Novo Nordisk Shares Plummet After Its Alzheimer’s Drug Trial Fails

The company said the weight loss and diabetes treatment drug failed to show any significant reduction in the progression of Alzheimer's disease in patients.

Raccontata da

lunedì 24 novembre 2025·cnbc.com
Novo Nordisk shares plunge 10% after Alzheimer's drug trial fails to hit key target
Shares of Novo Nordisk plunged after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer's disease failed to meet its main goal.
lunedì 24 novembre 2025·ft.com
Novo Nordisk shares slump after drug failure in Alzheimer’s trial
Outcome is blow to one of Europe’s largest listed companies

Novo Nordisk Shares Plummet After Its Alzheimer’s Drug Trial Fails

Novo Nordisk shares plunge 10% after Alzheimer's drug trial fails to hit key target

Novo Nordisk shares slump after drug failure in Alzheimer’s trial

Novo Nordisk se desploma en Bolsa ante los malos resultados de los ensayos de uno de sus fármacos contra el Alzhéimer

Novo Nordisk Shares Plummet After Its Alzheimer’s Drug Trial Fails

Novo Nordisk shares slide after Ozempic pill fails in Alzheimer’s trials